Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition

International Journal of Oncology
Jinfeng PanWeiping Min

Abstract

The significance of indoleamine 2,3-dioxygenase-1 (IDO1) has been studied in various types of tumors, but the relationship between IDO1 and tumor angiogenesis needs further delineation. We aimed to clarify the relationship between tumor angiogenesis and IDO1 expression, and to explore the possibility of IDO1-targeting molecular therapy for lung cancer. For the first time, we found that silencing the IDO1 gene using small interfering RNA (siRNA) inhibits in vitro cancer cell invasion and migration. We further demonstrated that knockdown of IDO1 decreased the formation of vasculogenic mimicry. In addition to these in vitro findings, we also demonstrated that in vivo IDO1 gene silencing using short hairpin RNA (shRNA) delayed tumor onset and inhibited tumor growth in the mouse model. Immunostaining showed that IDO1 gene silencing inhibited tumor angiogenesis. Moreover, the expression of IDO1 was associated with microvessel density (MVD) labeled by CD34 and CD146. These findings indicate that IDO1 has the potential to participate in or contribute to the formation of new capillaries, supporting the applicability of IDO1-targeting molecular therapy in lung cancer.

References

Dec 16, 1992·Journal of the National Cancer Institute·N WeidnerG Gasparini
Sep 17, 1999·The American Journal of Pathology·A J ManiotisM J Hendrix
Sep 21, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·G CoxK J O'Byrne
Mar 1, 2002·British Journal of Cancer·E PassalidouF Pezzella
May 10, 2003·Trends in Immunology·Ursula GrohmannPaolo Puccetti
Oct 2, 2004·Nature Reviews. Immunology·Andrew L Mellor, David H Munn
May 24, 2005·Journal of Medical Genetics·H CaldasR A Altura
Jan 19, 2006·The Journal of Investigative Dermatology·Yunyuan LiAziz Ghahary
Nov 23, 2006·British Journal of Cancer·K InoF Kikkawa
Aug 19, 2007·Cancer Biology & Therapy·Vaios KaranikasAnastasios E Germenis
Jul 16, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Chantal Feder-MengusMaurizio Provenzano
Jan 23, 2009·Nature·Martin Jinek, Jennifer A Doudna
Sep 29, 2009·The International Journal of Biochemistry & Cell Biology·Chaogu ZhengXiyun Yan
Sep 14, 2010·Trends in Biotechnology·Monica R LaresDominique L Ouellet
Jul 12, 2011·Biotechnology Journal·John C BurnettKatrin Tiemann
Nov 10, 2012·Molecular Medicine Reports·Sanaz VakiliReza Meshkani
Jun 3, 2014·Journal of Translational Medicine·Xusheng ZhangWei-Ping Min
Aug 2, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Wei-Wei BiDe-Zhi Nie
Jan 28, 2016·Thoracic Cancer·Rongshou ZhengWanqing Chen
May 20, 2016·Journal of Oral and Maxillofacial Pathology : JOMFP·Treville PereiraSandhya Tamgadge
Oct 13, 2016·Seminars in Respiratory and Critical Care Medicine·Valerie W Rusch

❮ Previous
Next ❯

Citations

Apr 3, 2018·International Journal of Cancer. Journal International Du Cancer·Xiuting LiuRong Hu
Aug 11, 2020·Journal of Cancer Research and Clinical Oncology·Sara PaccosiAstrid Parenti
May 13, 2018·International Journal of Cancer. Journal International Du Cancer·Yujuan ZhangWeiping Min

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.